WallStreetZenWallStreetZen

NASDAQ: BTAI
Bioxcel Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Bioxcel Therapeutics revenue was $2.27M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $366.0k, up 71% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BTAI annual revenue was $2.3M, with 64.2% growth year-over-year.

BTAI past revenue growth

How has BTAI's revenue growth performed historically?

Company
64.2%
Industry
497.69%
Market
20.68%
BTAI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BTAI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BTAI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BTAI revenue history

Current Revenue
$2.3M
Current Earnings
-$59.6M
Current Profit Margin
-2,630.1%

Be the first to know when BTAI announces revenue.

BTAI Revenue History By Year

BTAI Yearly RevenueBTAI RevenueBTAI ChangeBTAI Revenue Growth
2024-12-31$2.27M$886.00k+64.20%
2023-12-31$1.38M$1.01M+268.00%
2022-12-31$375.00kN/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A

1 of 1

Bioxcel Therapeutics Revenue FAQ

What was BTAI's revenue last quarter?

On Invalid Date, Bioxcel Therapeutics (NASDAQ: BTAI) reported Q4 2024 revenue of $366.00 thousand up 2.66% year over year. In the same quarter last year, Bioxcel Therapeutics's revenue was $376.00 thousand.

What was Bioxcel Therapeutics's revenue in 2024?

Bioxcel Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $2.27 million, a 64.2% increase year over year.

How much does Bioxcel Therapeutics make in a day?

Based on Bioxcel Therapeutics annual revenue for the past five years, BTAI makes an average of $2,203.29 per day.

What was Bioxcel Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Bioxcel Therapeutics's revenue has grown 64.2% year over year. This is 433.49 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Bioxcel Therapeutics's revenue in the past year totaled $2.27 million.

How much does Bioxcel Therapeutics make in a year?

Bioxcel Therapeutics's revenue by year for the past five years is:
  • Bioxcel Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $2.27 million, a 64.2% increase year over year.
  • Bioxcel Therapeutics's annual revenue for Dec 31, 2023 was $1.38 million, a 268% increase from 2022.
  • Bioxcel Therapeutics's annual revenue for 2022 was $375.00 thousand, a Infinity% increase from 2021.
  • Bioxcel Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Bioxcel Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.